OTC Markets Group announced Cannara Biotech (LOVFF) has qualified to trade on the OTCQX Best Market. Cannara Biotech Inc. upgraded to OTCQX from the OTCQB Venture Market.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LOVFF:
- Cannara Biotech Takes Top Market Share in Québec and Cleans Up Equity Compensation Plans
- Cannara Biotech provides update on Quebec vape category launch
- Cannara Biotech Reports Record Fiscal Year 2025
- Cannara Biotech Achieves Record Fiscal 2025 Performance and Market Expansion
- Cannara Biotech reports FY25 EPS C$0.14 vs. C$0.07 last year